Changes in drug prescription for asthma (A) and COPD (C) by GPs in Italy Source: Annual Congress 2010 - Pharmacological treatment in primary care Year: 2010
Prevalence rates of symptoms and diagnoses of chronic bronchitis (CB), emphysema (E) and asthma (A), with or without airflow obstruction (AO), in two Italian general population samples Source: Eur Respir J 2005; 26: Suppl. 49, 595s Year: 2005
Information exchange between primary care (PC) and secondary care (SC): What is considered important in COPD? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016
Study of 793 COPD patients treated by general practitioners (GPs), intensivists (IPs) and pulmonologists (Ps) across India Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015
Clinical implications of diagnosing underlying chronic bronchitis (CB) in at-risk patients (pts) with acute bronchitis (AB) visiting general practitioners (GPs) Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008
The level of asthma control in patients with asthma in primary care in Sweden. Results from the AIM-study (asthma in middle Sweden) Source: Eur Respir J 2002; 20: Suppl. 38, 395s Year: 2002
Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes Source: International Congress 2015 – Different data in COPD Year: 2015
An integrated care management program (ICMP) for patients with severe COPD; mortality, hazards and causes Source: International Congress 2015 – Best abstracts in chronic care Year: 2015
Application of the COMCOLD comorbidity index to a UK primary care COPD cohort Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015
GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort: Disease management in primary care: Descriptive data Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015
Association between chronic comorbidity and exacerbation rate in primary care COPD patients. Preliminary analysis of real-life general practice data (PROSPECT1) Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016
Validation of the COPD control concept: A UK pilot Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016
Provision of care for acute COPD in UK hospitals: survey of early discharge schemes (EDS) and pulmonary rehabilitation (PR) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008
Cardiovascular diseases (CVD), arterial hypertension (AH) and diabetes mellitus (DM) in a cohort of 609 COPD patients: Associations with the new GOLD classification 2011 Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013
One year with certified asthma and COPD-clinics in Skåne, Sweden Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015
Economic effectiveness of integrated care model (ICM) for patients with severe chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015
Real life management of chronic obstructive pulmonary disease (COPD) in general practice (GP) in Denmark Source: International Congress 2015 – Respiratory disease management in primary care Year: 2015
Evaluating health care resource consumption in chronic obstructive pulmonary disease (COPD) patients (VICE Study) Source: Eur Respir J 2006; 28: Suppl. 50, 35s Year: 2006
Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE) Source: Annual Congress 2013 –COPD biomarkers Year: 2013
Efficacy of indacaterol/glycopyrronium (IND/GLY) versus salmeterol/fluticasone (SFC) on exacerbations and health status in GOLD Group D COPD patients: The FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016